|
Diet Drug Acomplia (Rimonabant) Still Seen as a Winner by Sanofi
2008-04-24 21:46:00 Quantity Strength Price(Usd) Online Pharmacy 28 Tab(s) 20mg $ 59.00 Buy(Order) 56 Tab(s) 20mg $109.00 Buy(Order) 84 Tab(s) 20mg $135.00 Buy(Order) 168 Tab(s) 20mg $255.00 Buy(Order) 336 Tab(s) 20mg $479.00 Buy(Order) Sanofi-Aventis said on April 3rd it still has high hopes for diet drug rimonabant (Acomplia / Zimulti), even though it was rejected by a U.S. FDA advisory panel last year and recent clinical trial news has been ...
Acomplia Sanofi: Re-Defining Your Body Shape
2008-04-21 00:20:00 Pondering over weight loss? With obesity spreading far and wide, entrapping young and old alike in its ambit, it is important to find a solution to this health hazard. Weight loss pills which have made their presence felt in the recent past, can offer you a solution. Among the enormous list of weight loss pills ...
Diet Drug Acomplia is a winner - Sanofi Declared
2008-04-12 15:50:00 Sanofi-Aventis,one of the biggest company in the drug?s field said on April 3rd it still has high hopes for Acomplia, even though it was rejected by a U.S. FDA advisory panel last year . Marc Cluzel, Sanofi’s head of research, said in a round of interviews in London that he continues ...
Acomplia by Sanofi-Aventis: Re-Defining Your Body Shape
2008-04-10 22:00:00 Pondering over weight loss? With obesity spreading far and wide, entrapping young and old alike in its ambit, it is important to find a solution to this health hazard. Weight loss pills which have made their presence felt in the recent past, can offer you a solution. Among the enormous list of weight loss pills ...
By: Rimonabant 2007
Rimonabant (Acomplia/Zimulti) Still a Winner in Sanofi?s Eyes
2008-04-06 12:26:00 On April 3rd Sanofi-Aventis published that it still has high hopes for Rimonabant (Acomplia / Zimulti) to get aproval from the FDA in US, even though it was rejected by an advisory panel last year and recent clinical trial news has been less than wildly encouraging. Marc Cluzel, Sanofi’s head of research, said in a ...
Despite that Acomplia Sales are Low, Sanofi Has High Hopes
2008-02-26 10:29:00 With sales of Acomplia (rimonabant) is low in the several dozen countries where it is on the market, Sanofi-Aventis executives had little to say about their pioneering obesity treatment in a report to analysts on Feb. . But that hardly means they have given up on the CB-1 receptor antagonist. Instead, Sanofi unveiled plans to make ...
Sales of Acomplia Lag, But Sanofi Still Has High Hopes for Rimonabant
2008-02-15 19:04:00 With sales of Acomplia (rimonabant) lagging in the several dozen countries where it is on the market, Sanofi-Aventis executives had little to say about their pioneering obesity treatment in a report to analysts on Feb. 12th. But that hardly means they have given up on the CB-1 receptor antagonist. Instead, Sanofi unveiled plans to make at ...
Diet Drug Taranabant Could Pass Fda Test This Summer ,despite Sanofi?s Effo
2008-02-05 09:07:00 FDA approval of diet drug rimonabant (Acomplia ) failed. That did not happen — in fact, rimonabant may never make it to market in the U.S, and the great diet hope for 2008 is Merck’s diet drug taranabant. Everybody knows that there is a big rivality between Sanofi and Merk. Despite all the efforts Sanofi Aventis failed ...
Generic acomplia Sanofi Aventis
2008-01-22 09:42:00 Generic acomplia Sanofi Aventis Info related to acomplia Sanofi Aventis Generic Acomplia Rimonabant Zimulti available in Market now We now offer Generic Rimonabant Zimulti Acomplia information to users which is available to ship worldwide. See below for more information about Generic Acomplia Rimonabant 20 Mg We also offer Branded Acomplia Rimonabant which is manufactured by Sanofi-Aventis. Rimonabant is sold under ...
Acomplia Sanofi
2008-01-19 00:05:00 Sanofi-Aventis, a drug company based in France, developed and tested Acomplia (Rimonabant). The new drug appears to be exceptionally effective in treating not only obesity but in helping to reduce weight-related risk factors for heart disease and other conditions. Acomplia has been on the market in Europe since 2006, and it is quickly gaining attention ...
Rimonabant, Sanofi Avensis and FDA
2008-01-18 23:23:00 Despite the FDA issuing an approvable letter in February 2006 for the obesity indication and a non-approvable letter for smoking cessation, the drug did not enter the market in the United States in 2006.The French pharma firm Sanofi-Aventis disclosed that a complete response to the FDA’s approvable letter was submitted on October 26, 2006, triggering ...
Sanofi-Aventis Response To BMJ Article On Obesity Drugs Achieving Modest We
2007-11-19 21:08:00 The British Medical Journal recently published an article stating that most obesity drugs achieve 'modest' weight loss. Below is the response from Sanofi-Aventis. [click link for full article]
Sanofi-Aventis Response To BMJ Article On Obesity Drugs Achieving Modest We
2007-11-19 21:08:00 The British Medical Journal recently published an article stating that most obesity drugs achieve 'modest' weight loss. Below is the response from Sanofi-Aventis. [click link for full article]
The big launch of Acomplia in the UAE was announced by Sanofi-Avensis
2007-10-21 22:48:00 An announcement was made about Sanofi-Aventis.This refears to the launch of Acomplia (rimonabant), a new medication that treats abdominally obese persons which presents cardio metabolic risk cluster. This medication was approved from the European Medicines Evaluation Agency (EMEA) in order to be used,but combined with diet and sport and it?s ...
Sanofi has declared that they don?t plan trying to sell diet medication Aco
2007-10-21 22:38:00 For the next three or four years Sanofi-Aventis sais that they will not try to sell diet medication acomplia rimonabant in the United States. The company declared that on Sept. 17th. But they also showed that they still have high expectations for acomplia rimonabant, specially as a treatment for type 2 ...
By: Rimonabant FDA
Acomplia Sanofi Aventis: Messiah For The Obese
2007-10-08 22:34:00 Acomplia is a Sanofi Aventis creation, which is a large cap French pharmaceutical firm. Weight loss medication Acomplia is a product of two years of clinical trials undertaken in North America. Weight loss is not the only benefit which is sourced by use of this diet pill. Usage of this weight loss medication has also ...
By: Rimonabant 2007
Acomplia Sanofi: Re-modelling Your Body Shape
2007-10-08 22:29:00 Pondering over weight loss? With obesity spreading far and wide, entrapping young and old alike in its ambit, it is important to find a solution to this health hazard. Weight loss pills which have made their presence felt in the recent past, can offer you a solution. Among the enormous list of weight loss pills ...
Flu Shots: Kudos to Sanofi Pasteur
2007-09-04 12:31:00 As many of you know who regularly read this blog, my pulse rises a little bit when talking about flu shots. (image credit) I admit that I directed much of this frustration at the companies who produce the flu shots. Check out my posts - Flu Shot Rant and Flu Shot Rant: Part Deux.Someone in my office mentioned flu shots last week. As my almost started another rant right there in the office, my staff told me that we just received our first partial shipment of flu shots from Sanofi Pasteur. Hmmmm.... That's interesting.As I did some investigating on this, I found this news story from the AP and I also found a press release from about three weeks ago.Swiftwater, PA. - Sanofi Pasteur, the vaccines division of Sanofi-Aventis SA, has started shipping the first of about 50 million doses of flu vaccine it expects to produce this season.The first doses are being shipped to the Centers for Disease Control and Prevention to support the Vaccines For Children program and to private doctors and o...
By: Doctor Anonymous
Acomplia online order, aventis sanofi acomplia buy
2007-09-03 07:13:00 Buy Acomplia About 2 in 5 adults you come across in the UK are overweight ? this problem is not only restricted to UK but also affects increasing number of people across the world. Exercises and diets do help, but a weight loss drug is your safest option helping you to get rid of those unwanted ...
Sanofi-Aventis announce the launch of Acomplia in the UAE
2007-08-27 18:44:00 Sanofi-Aventis announced the launch of Acomplia (rimonabant), their new scientific drug for the treatment of abdominally obese patients with cardio metabolic risk cluster. The drug has received approval from the European Medicines Evaluation Agency (EMEA) to be used in combination with diet and exercise for the treatment of abdominal obesity with cardio metabolic risk cluster, and ...
Sanofi Pulls U.S. Application for Approval of Diet Drug Acomplia (Rimonaban
2007-08-25 19:16:00 Sanofi-Aventis on June 29th temporarily ended its effort to get diet drug rimonabant (Acomplia / Zimulti) approved for sale in the United States, withdrawing its application rather than await next month?s near-certain rejection by the U.S. Food and Drug Administration. The action came less than two weeks after the FDA?s expert advisory committee unanimously recommended that ...
Sanofi Slimming Pill -Acomplia miracle diet pill
2007-08-23 06:37:00 Sanofi-Sythelabo’s attempts to acquire Aventis is the fact that the company just released great phase 3 data on a pill that would help stop two of the nation’s biggest killers — smoking and obesity. The drug, rimonabant, or Acomplia, packs a wicked combination punch. It helped roughly one-third of smokers quit and without gaining weight. In ...
Sanofi to Improve ?Communication,? But Not About FDA and Diet Drug Acomplia
2007-08-21 22:27:00 The new chief executive of Sanofi Aventis, Gérard Le Fur, says the company needs to improve its ?communication,? but not by disclosing why diet drug Acomplia (rimonabant) has been stalled for more than a year at the U.S. Food and Drug Administration. Le Fur, the former research chief at Sanofi who took over this month as ...
Sanofi Presented New Acomplia Data at March 8 2005 Meeting
2007-08-21 22:27:00 Sanofi-Aventis indicated on January 26th that the millions of obese and overweight individuals eagerly waiting for additional information from the clinical trials being conducted for highly publicized Acomplia (rimonabant) are going to have to wait another six weeks for the next update. In a news release that focused largely on the company?s 2004 financial results, Sanofi-Aventis ...
Sanofi Expresses Confidence Acomplia Will Be Available in U.S. in a Few Mon
2007-08-21 22:26:00 Sanofi-Aventis, developer of Acomplia (rimonabant), told financial analysts on Jan. 30th it is ?very, very confident? it will be permitted to begin selling the highly anticipated weight-loss drug in the United States in the spring of this year. ?We can only report that our collaboration with the FDA is excellent. We have developed the product in ...
Sanofi to Present More Acomplia Data at April 11th Meeting
2007-08-21 22:25:00 Sanofi-Aventis, developer of the highly publicized anti-obesity drug Acomplia, will present new data on the drug?s role in reducing metabolic cardiovascular disease risk factors at a scientific meeting in San Diego April 11th and 12th. Dr. Pierre Rosenzweig, a Vice President of Sanofi-Aventis, will make the presentation at the Annual Metabolic Diseases Drug Discovery World ...
Most Significant ?Wait Loss? for Diet Drug Acomplia Is Loss of Sanofi?s Hug
2007-08-21 22:24:00 As month after month passes with no sign of imminent FDA action on diet drug rimonabant (Acomplia / Zimulti), the most significant ?wait loss? taking place is loss of the hugh lead Sanofi-Aventis once had in developing a novel approach to weight-loss based on blocking the CB-1 receptors in the brain. A year ago, the French ...
Australian Acomplia Study, Sanofi To Challenge Acomplia Decision By German
2007-08-20 20:23:00 “Perth researchers will test a new anti-obesity pill on West Australians in the hope it will not only help them lose weight but reduce their risk of heart disease by boosting levels of HDL, or ?good? cholesterol. The Royal Perth Hospital study, part of an international trial, could prove the weight-loss pill rimonabant, sold as Acomplia, ...
FDA Had Bad News on Acomplia for Sanofi
2007-08-19 13:32:00 When the U.S. Food and Drug Administration on Feb. 17th told Sanofi-Aventis that it was going to delay a decision on approving its much anticipated weight-loss drug Acomplia (rimonabant) until certain conditions were met, that was certainly bad news for the French pharmaceutical giant. But until Sanofi sheds some light on the nature of those conditions, ...
Sanofi Says No New Weight-Loss Trial Needed for Acomplia Approval
2007-08-19 13:31:00 February 2006 - Sanofi-Aventis said on Feb. 22nd that the U.S. Food and Drug Administration has not requested a new trial of the drug Acomplia (rimonabant) prior to possible approval of the highly anticipated drug for use in promoting weight-loss. As a result, Sanofi executives held open the possibility that the drug may still be on the ...
Is There Any Factual Basis for Sanofi?s Latest Optimism on Acomplia Approva
2007-08-19 13:30:00 Is there any factual basis on which to believe the FDA will approve weight-loss drug Acomplia (rimonabant) for sale in the United States before the end of 2006, or are we once again left only with an optimistic forecast ? and no supporting details ? from the ever-optimistic Sanofi-Aventis management? Well, for a man who was ...
Sanofi Explains Why Diet Pill Acomplia Will Be Diet Drug Zimulti in U.S.
2007-08-18 13:30:00 After more than a year of asking, we now have Sanofi?s official explanation why diet drug rimonabant ? sold as Acomplia in Europe and the rest of the world ? will be marketed in the United States (if and when it is approved) as Zimulti. According to Hanspeter Spek, Sanofi?s executive vice president for pharmaceutical operations, ...
Sanofi ?Examining Options? Against Sellers Offering Generic Rimonabant (Aco
2007-08-17 17:59:00 Sanofi-Aventis, developer of diet drug rimonabant (Acomplia / Zimulti), said on May 24th it was ?examining all legal options? in light of the emergence of three different companies offering generic versions of rimonabant in India. The development puts Sanofi in the odd position of facing generic competition that could spread worldwide via the internet even as ...
Sanofi Withdraws Bid to Sell Diet Drug Acomplia (Rimonabant) in United Stat
2007-08-16 10:57:00 The effort to get diet drug rimonabant (Acomplia / Zimulti) approved for sale in the United States temporarily ended on June 29th, when Sanofi-Aventis withdrew its application rather than await next month’s near-certain rejection by the U.S. Food and Drug Administration. The action followed the crushing vote two weeks ago of the FDA’s expert advisory committee, which unanimously recommended that sale of rimonabant not be permitted in the United States pending further study of rimonabant’s link to an increased risk of depression and suicidality. Sanofi, in a statement, said it would “undertake the necessary discussions with the FDA to determine” what additional data is needed before resubmitting its application, which will likely not occur until 2010. But, the company added, “Sanofi-Aventis is committed to making all efforts necessary to make rimonabant available to patients in the U.S. market.” Rimonabant, the first weight-loss drug which works by blocking CB-1 recepto...
Sanofi: Diet Drug Acomplia Requires Indefinite Use to Keep Weight Off
2007-08-16 10:57:00 Diet drug Acomplia (rimonabant) users might want to pay close attention to an issue that developer Sanofi-Aventis is now facing the need to address more openly with regulators (if not dieters): If you want to keep off the weight you lose on Acomplia, you need to take the drug daily for the rest of your life. Marc Cluzel, senior vice president for scientific and medical affairs of Sanofi, told analysts Sanofi withdrew its application to sell rimonabant in the United States because it felt there would not be adequate time before July’s expected FDA decision to discuss issues raised by the FDA advisory panel linked to “duration of treatment.” In the Phase III clinical trials for Acomplia, patients who were on rimonabant for a year lost up to 10 percent of their body weight. But while those who continued on Acomplia for a second year maintained their weight loss, those switched to a placebo tended to quickly regain the weight. That would strongly suggest that to keep weight lost w...
Sanofi Still Hoping Diet Drug Acomplia Will Make It to U.S. Market
2007-08-15 11:22:00 anofi-Aventis still believes there is a good chance diet drug Acomplia (rimonabant) ultimately will be approved by the U.S. Food and Drug Administration for marketing in the United States, according to the company?s head of German operations Heinz-Werner Meier. ?That subject has not yet been written off,? Sanofi?s head of German operations Heinz-Werner Meier told the ...
Sanofi Holds Little Hope for Early U.S. Sale of Acomplia / Zimulti (Rimonab
2007-08-15 11:21:00 Diet drug Acomplia / Zimulti (rimonabant) has now been taken by more than 200,000 obese and overweight patients in Europe and a handful of other countries, but Sanofi-Aventis offered no encouragement on Aug. 1 to those hoping to see it approved for early sale in the United States. Executive Vice President Hanspeter Spek, talking to financial ...
acomplia sanofi aventis - Sanofi-Aventis Acomplia provides long term cardio
2007-08-12 22:46:00 New data shows that Sanofi-Aventis’ developmental drug Acomplia (rimonabant) significantly improved blood sugar levels in trial patients with Type 2 diabetes, while also reducing body weight. The new data comes from Sanofi-Aventis’ first non-obesity trial with Acomplia. The results of the six month trial, dubbed …acomplia sanofi aventis Sanofi-Aventis SA says Acomplia, its new antiobesity drug, ...
Acomplia aventis rimonabant sanofi
2007-08-11 15:45:00 acomplia aventis rimonabant sanofi Top acomplia aventis rimonabant sanofi Resources Our Top acomplia aventis rimonabant sanofi Resource Rimonabant acomplia Best source for rimonabant acomplia, compare prices Click Here Right Now More acomplia aventis rimonabant sanofi Resources Buy Acomplia Rimonabant.com BuyAcompliaRimonabant.com - your discreet interface to order acomplia rimonabant online! Learn about acomplia rimonabant and buy acomplia rimonabant online with complete confidence. Acomplia - Acomplia ...
Sanofi Drug Hits New Hurdle With Indian Knockoffs
2007-08-10 05:12:00 Sanofi-Aventis SA's "Acomplia" the weight- loss pill, linked to suicide, is becoming popular in generic form from India which may end the product's chances of ever reaching the U.S., where it has been delayed by regulators. Cipla Ltd. and Ranbaxy Laboratories Ltd. are among six drugmakers exploiting a loophole in India patent laws, selling copies of the medicine under names like Slimona and Defat. The pills are sold without prescription for as little as 12 cents. Sanofi had predicted Acomplia would generate $3 billion a year. Sanofi's earnings have dropped for four straight quarters. The drugmaker is losing patent protection on older medicines such as the sleep pill Ambien. Sanofi withdrew its U.S. marketing application for Acomplia on June 29 after the FDA raised safety concerns. Under Indian intellectual property law, pharmaceutical companies can use a process called reverse engineering to make drugs patented before 1995. T...
Vexing Month for Sanofi Over Rimonabant Likely to Hit Peak in Coming Week
2007-08-10 02:25:00 What has been vexing month for Sanofi-Aventis and its highly anticipated diet pill rimonabant (Acomplia / Zimulti) — with the introduction of competing versions of rimonabant in India before the drug Sanofi originated has been approved for sale — seems likely to reach a peak in the week ahead. On Tuesday, June 12th, the U.S. FDA ...
Sanofi Hopes to Receive new Data for Acomplia by the end of 2008 to 2010
2007-08-07 18:28:00 Despite of the fact that Acomplia has been rebuffed by the U.S. FDA's advisory panel in June
By: Rimonabant
FDA hatte schlechte Nachrichten auf Acomplia für Sanofi
2007-08-05 22:08:00 Februar 2006 - Als die USnahrungsmittel-und Droge-Leitung Sanofi-Aventis, daß erklärte am 17. Feb. es zu ging, verzögert eine Entscheidung über das Genehmigen seiner viel vorweggenommenen Gewichtverlust Droge Acomplia (rimonabant) bis bestimmte Bedingungen getroffen waren, das war zweifellos schlechte Nachrichten für den französischen pharmazeutischen Riesen. Aber, bis Sanofi etwas Licht auf der Natur jener Bedingungen verschüttet, wissen wir ...
Sanofi sagt kein neuer Gewicht-Verlust Probeerforderliches für Acomplia Zus
2007-08-05 22:07:00 Februar 2006 - Sanofi-Aventis sagte, am 22. Feb. daß die USnahrungsmittel-und Droge-Leitung um einen neuen Versuch der Droge Acomplia (rimonabant) nicht vor möglicher Zustimmung der in hohem Grade vorweggenommenen Droge für Gebrauch gebeten hat, wenn sie Gewichtverlust förderte. Infolgedessen öffnen die gehaltenen Sanofi Hauptleiter die Möglichkeit, daß die Droge auf dem Markt in den Vereinigten Staaten ...
Sanofi Holds Little Hope for Early U.S. Sale of Acomplia / Zimulti (Rimonab
2007-08-05 19:13:00 Diet drug Acomplia / Zimulti (rimonabant) has now been taken by more than 200,000 obese and overweight patients in Europe and a handful of other countries, but Sanofi-Aventis offered no encouragement on Aug. 1 to those hoping to see it approved for early sale in the United States. Executive Vice President Hanspeter Spek, talking to financial ...
Sanofi presentó los nuevos datos de Acomplia en la reunión del 8 de marzo d
2007-08-02 04:22:00 Sanofi-Aventis indicó el 26 de enero que millones de individuos obesos y gordos que esperan con impaciencia la información adicional de los ensayos clínicos que son conducidos para Acomplia altamente publicado (rimonabant) van a tener que esperar otros seis semanas la actualización siguiente. En noticias lanzar eso centrada en gran parte en los resultados financieros de ...
Sanofi expresa la confianza Acomplia estará disponible en los E.E.U.U. en a
2007-08-02 04:15:00 Enero de 2006 Sanofi-Aventis, revelador de Acomplia (rimonabant), dicho analistas financieros que el 30 Ene está ?muy, muy confidente? él será permitido para comenzar a vender la droga altamente anticipada de la peso-pérdida en los Estados Unidos en el resorte de este ańo. ?Podemos divulgar solamente que nuestra colaboración con el FDA es excelente. Hemos desarrollado el ...
Sanofi para presentar más datos de Acomplia en la reunión del 11 de abril
2007-08-02 04:08:00 Febrero de 2005 Sanofi-Aventis, revelador de la droga altamente publicada Acomplia de la contra-obesidad, presentará nuevos datos sobre el papel de la droga en la reducción de factores de riesgo metabólicos de la enfermedad cardiovascular en una reunión científica en San Diego el 11 y 12 de abril. El Dr. Pierre Rosenzweig, vice presidente de Sanofi-Aventis, hará ...
Sanofi dice que Acomplia podría ser en mercado antes del 30 de junio si el
2007-08-02 04:03:00 Febrero de 2006 Sanofi-Aventis, revelador de la droga Acomplia de la peso-pérdida de la novela (rimonabant), continúa haciendo alusión que espera que el FDA de los E.E.U.U. apruebe la droga en las semanas próximas - permitir a doctores comenzar a prescribirla antes de finales de junio. El investigador de Philadelphia divulgó el 4 Feb que si Acomplia ...
Sanofi Says Acomplia Could Be on Market by June 30th if FDA Gives OK in Feb
2007-08-02 01:34:00 February 2006 Sanofi-Aventis, developer of the novel weight-loss drug Acomplia (rimonabant), continues to hint that it expects the U.S. FDA to approve the drug in the next few weeks — enabling doctors to begin prescribing it before the end of June. The Philadelphia Inquirer reported on Feb. 4th that If Acomplia gets marketing approval from the FDA ... |
|
 |
|
 |
